bioRxivPharmacology & Toxicology
The Pharmacodynamic-Toxicodynamic Relationship of AUC and CMAX in Vancomycin Induced Kidney Injury in an Animal Model
S. Avedissian, G. Pais, J. Liu, J. N. O'Donnell, T. Lodise, M. Neely, W. Prozialeck, P. Lamar, L. Becher, M. H. Scheetz
Abstract
BackgroundVancomycin induces exposure-related acute kidney injury. However, the pharmacokinetic-toxicodynamic (PK-TD) relationship remains unclear. MethodsSprague-Dawley rats received IV vancomycin doses of 300mg/kg/day and 400mg/kg/day, divided once, twice, thrice or 4xdaily (i.e., QD, BID, TID or QID) over 24-hours. Up to 8-samples were drawn during the 24-hour dosing period. Twenty-four-hour urine was collected and assayed for kidney injury molecule-1 (KIM-1). Vancomycin was quantified via LC-MS/MS. Following terminal sampling, nephrectomy and histopathologic analyses were conducted. PK analyses were conducted using Pmetrics. PK exposures (i.e. AUC0-24h, CMAX0-24h,) were calculated for each rat, and PK-TD relationships were discerned. ResultsA total of 53-rats generated PK-TD data. A 2-compartment model fit the data well (Bayesian observed vs. predicted concentrations, R2=0.96). KIM-1 values were greater in QD and BID groups (P-values: QD vs TID:<0.002, QD vs QID:<0.004, BID vs TID:<0.002, and BID vs QID:<0.004). Exposure-response relationships were observed between KIM-1 vs CMAX0-24h and AUC0-24h (R2{square}={square} 0.7 and 0.68). Corrected Akaikes information criterion showed CMAX0-24h as most predictive PK-TD driver for vancomycin-induced kidney injury (VIKI) (-5.28 versus -1.95). ConclusionsWhile PK-TD indices are often inter-correlated, maximal concentrations and fewer doses (for the same total daily amount) resulted in increased VIKI in our rat model.
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Of Rats and Men, a Translational Model to Understand Vancomycin Pharmacokinetic/Toxicodynamic relationships
M. H. Scheetz, G. Pais, … T. Holland·bioRxiv·Apr 22, 2021
- Urinary biomarker and histopathological evaluation of vancomycin and piperacillin-tazobactam nephrotoxicity in comparison with vancomycin in a rat model and a confirmatory cellular model
G. M. Pais, J. Liu, … M. H. Scheetz·Journal of Antimicrobial ChemotherapyPeer-reviewed·Feb 3, 2020
- Impact of vancomycin loading doses and dose escalation on glomerular function and kidney injury biomarkers in a translational rat model
J. Chang, G. Pais, … M. H. Scheetz·bioRxiv·Sep 26, 2022
- Protamine Protects Against Vancomycin Induced Kidney Injury
Justin Shiau, Patti L. Engel, … Marc H. Scheetz·Antimicrobial Agents and ChemotherapyPeer-reviewed·Jan 17, 2025
- Iohexol-measured glomerular filtration rate and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model
J. Chang, G. Pais, … M. H. Scheetz·bioRxiv·Mar 9, 2023
- Glomerular function and urinary biomarker changes between vancomycin and vancomycin plus piperacillin-tazobactam in a translational rat model.
J. Chang, G. Pais, … M. H. Scheetz·bioRxiv·Nov 8, 2021